Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06174038 · ClinicalTrials.gov registry record · NA

Early Age-Related Hearing Loss Investigation (EARHLI)

A NA study of Alzheimer Disease and Cognitive Impairment, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06174038 is a NA study of Alzheimer Disease and Cognitive Impairment that is actively recruiting participants, run by Columbia University. The registered enrollment target is 150 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06174038, a NA study of Alzheimer Disease and Cognitive Impairment, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).

Interventions

  • BEHAVIORAL Health Education Intervention
  • DEVICE Hearing Intervention

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-08-01
Est. Completion 2027-12-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06174038

The ClinicalTrials.gov registry entry for NCT06174038 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Health Education Intervention is the first listed.

NCT06174038 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06174038 about?

NCT06174038 is a clinical study titled "Early Age-Related Hearing Loss Investigation (EARHLI)". Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reduc...

What is the current status of trial NCT06174038?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-08-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06174038 study?

This clinical trial studies the following conditions: Alzheimer Disease, Cognitive Impairment, Hearing Loss.

What interventions are being tested in trial NCT06174038?

The interventions under investigation include: Health Education Intervention (BEHAVIORAL), Hearing Intervention (DEVICE).

Who is sponsoring clinical trial NCT06174038?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06174038 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.